Health Technology Assessment Conference 2013
December 5 - 6, 2013
Sydney , Australia
KEYNOTE SPEAKERS INCLUDE:
> Medical Benefits Division, Department of Health and Ageing - Speaker to be Confirmed
> Robyn Ward, Chair, Medical Services Advisory Committee (MSAC), Department of Health and Ageing
> Ruth Lopert, Principal Adviser Market Authorization, Therapeutic Goods Administration (TGA), Department of Health and Ageing
> Brendon Kearney, Chair, HealthPACT and Site Clinical Director, Royal Adelaide Hospital
> Anne Kolbe, Chair, National Health Committee New Zealand
> Faye Sumner, Chief Executive Officer, Medical Technology Association of New Zealand
> Adam Elshaug, Principal Research Fellow, Menzies Centre for Health Policy, The University of Sydney
> Peggy McBride, Health Economics and Outcomes Manager, Medtronic Australasia Pty Ltd.
A COMPREHENSIVE PROGRAM ADDRESSING:
> Policy, Standards and Guidelines
> Reforms To The Regulation Of Pharmaceuticals
> Exploring Innovative Approaches To HTA For Medical Procedures And Diagnostics
> Disinvestment Decision Making
> HTA Case Studies: Decision Making in Hospital Based Organisations
> Community Engagement in HTA
> Ethics and HTA
> Evidence for HTA
> HTA Methodology: Meeting Challenges and Adjusting Evaluation
INTERACTIVE PANEL DISCUSSIONS:
> Choosing The Right Assessment Method For Non-Drug Technologies: Observational Studies vs. Randomised Control Trials (RCT)
> Incorporating Ethics and Community Perspectives Into HTA In Australia: What Are The Drivers For And Barriers To Incorporating These Perspectives?
PRE-CONFERENCE WORKSHOP: WEDNESDAY 4TH DECEMBER 2013 9am - 5pm
Understanding The Australian Co-Dependent Technology Evaluation Framework When Applied To Personalised Medicines And Companion Diagnostic Tests.
> Medical Benefits Division, Department of Health and Ageing - Speaker to be Confirmed
> Robyn Ward, Chair, Medical Services Advisory Committee (MSAC), Department of Health and Ageing
> Ruth Lopert, Principal Adviser Market Authorization, Therapeutic Goods Administration (TGA), Department of Health and Ageing
> Brendon Kearney, Chair, HealthPACT and Site Clinical Director, Royal Adelaide Hospital
> Anne Kolbe, Chair, National Health Committee New Zealand
> Faye Sumner, Chief Executive Officer, Medical Technology Association of New Zealand
> Adam Elshaug, Principal Research Fellow, Menzies Centre for Health Policy, The University of Sydney
> Peggy McBride, Health Economics and Outcomes Manager, Medtronic Australasia Pty Ltd.
A COMPREHENSIVE PROGRAM ADDRESSING:
> Policy, Standards and Guidelines
> Reforms To The Regulation Of Pharmaceuticals
> Exploring Innovative Approaches To HTA For Medical Procedures And Diagnostics
> Disinvestment Decision Making
> HTA Case Studies: Decision Making in Hospital Based Organisations
> Community Engagement in HTA
> Ethics and HTA
> Evidence for HTA
> HTA Methodology: Meeting Challenges and Adjusting Evaluation
INTERACTIVE PANEL DISCUSSIONS:
> Choosing The Right Assessment Method For Non-Drug Technologies: Observational Studies vs. Randomised Control Trials (RCT)
> Incorporating Ethics and Community Perspectives Into HTA In Australia: What Are The Drivers For And Barriers To Incorporating These Perspectives?
PRE-CONFERENCE WORKSHOP: WEDNESDAY 4TH DECEMBER 2013 9am - 5pm
Understanding The Australian Co-Dependent Technology Evaluation Framework When Applied To Personalised Medicines And Companion Diagnostic Tests.
Venue
Location: Sydney Harbour Marriott Hotel
The Sydney Harbour Marriott Hotel at Circular Quay is one of the premier Sydney Harbour hotels, surrounded by spectacular waterside views of the Sydney Opera House and Sydney Harbour Bridge. This..
+61292597000
Related events
Annual Health Technology Assessment Conference November 24 - 25, 2014
Health Technology Assessment Conference December 5 - 6, 2013
